Plasma VEGF determination in disseminated lymphangiomatosis-Gorham-Stout syndrome: a marker of activity? A case report with a 5-year follow-up

Bone
Jean-Louis DupondMarjolaine de Billy

Abstract

Disseminated lymphangiomatosis and Gorham-Stout disease are being considered as two forms of a single rare disease, characterized by a proliferation of lymphatic vessels, triggered by lymphangiogenic factors. There is no biological marker of the disease. Plasma VEGF might be a useful tool since the recent demonstration of its pivotal role in the mechanism of this disease. A 45-year-old woman with a history of disseminated lymphangiomatosis involving mediastinum, retroperitoneum, spleen and systemic bones for 29 years was treated with Interferon alpha 2b at a dosage of 7.5 to 15 million IU 3 times a week for 5 years. Plasma VEGF quantification was performed twice a year and showed a marked increase before therapy, which normalize after 18 months of treatment with Interferon. The normalization of plasma VEGF is correlated with the clinical improvement objectively appraised by a marked reduction of spleen lesions and significant improvement of the other damages in soft tissues and bones. Thus, we conclude that plasma VEGF determination should be considered for diagnosis and follow-up of the course and the treatment of disseminated lymphangiomatosis-Gorham-Stout disease.

References

Mar 11, 2000·American Journal of Respiratory and Critical Care Medicine·J L FaulT A Raffin
Aug 3, 2002·Nature Reviews. Cancer·Steven A StackerKari Alitalo
Mar 20, 2003·Journal of the National Cancer Institute·Zofia von MarschallStefan Rosewicz
Aug 6, 2004·Endocrine Reviews·Napoleone Ferrara
Jul 12, 2005·Pediatric Blood & Cancer·Christian TimkeAlexander Claviez
Sep 6, 2008·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Ene T RaigWilliam E Carson

❮ Previous
Next ❯

Citations

Dec 27, 2011·Lymphatic Research and Biology·K D Gordon, P S Mortimer
Dec 12, 2012·Lymphatic Research and Biology·Juan C Lopez-GutierrezJuan A Tovar
Oct 22, 2010·Journal of Pediatric Hematology/oncology·Dawn K KuriyamaKaren S Thompson
Jul 25, 2012·Pediatric Dermatology·Inês LeiteAntonio Torrelo
Mar 13, 2015·Iranian Red Crescent Medical Journal·Abolghasem Daneshvar KakhakiRoya Farzanegan
Sep 1, 2014·Microvascular Research·Stanley G Rockson
Oct 22, 2014·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·C MaillotJ-C Le Huec
Sep 20, 2011·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·Yi HuangLongjiang Li
Jun 11, 2015·American Journal of Medical Genetics. Part a·Takeshi SatoMasanori Adachi
Feb 8, 2011·Pediatric Blood & Cancer·Rajkumar VenkatramaniLeo Mascarenhas
May 25, 2011·Acta Paediatrica·Nicholas BrodszkiErik A Eklund
Sep 4, 2013·Pediatric Pulmonology·Vered NirLea Bentur
Nov 12, 2013·Pediatric Blood & Cancer·Jeroen HagendoornDavid H Ebb
Mar 4, 2014·Bone·Michael T DellingerBjorn R Olsen
Jul 31, 2013·Journal of Zhejiang University. Science. B·Po HuJian-an Wang
Oct 29, 2013·The Spine Journal : Official Journal of the North American Spine Society·Yohei KakutaKenji Takagishi
Jul 6, 2013·International Journal of Pediatric Otorhinolaryngology·Noriko MorimotoNobuhito Morota
Sep 6, 2014·Lymphatic Research and Biology·Mordechai FindlerElad Sharon
Jan 5, 2017·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Wensheng WangLianping Xing
Mar 30, 2012·Pediatric Neurosurgery·Carmen Hernández-MarquésDaniel Azorín Cuadrillero
Aug 25, 2017·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Inna G StrohNeil R Miller
Jun 18, 2019·Pediatric Blood & Cancer·Michio OzekiToshiyuki Fukao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Related Papers

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
Fabian HammerWiebke Arlt
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
Silvia ColucciFederico Bussolino
International Journal of Radiation Oncology, Biology, Physics
Reinhard HeydGerman Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD)
© 2022 Meta ULC. All rights reserved